AP NEWS

Twist Bioscience to Report Fiscal 2018 Fourth Quarter and Full Year Financial Results on Wednesday, December 19, 2018

December 5, 2018

SAN FRANCISCO--(BUSINESS WIRE)--Dec 5, 2018--Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it will issue its financial results for the fourth quarter and fiscal year ended September 30, 2018 following the close of market on Wednesday, December 19, 2018. The company plans to hold a conference call and live audio webcast for analysts and investors at 4:30 p.m. Eastern Time to discuss its financial results and provide an update on the company’s business. The press release with the financial results will be accessible from the company’s website prior to the conference call through the Investor Relations section under the “company” tab at www.twistbioscience.com.

The call can be accessed by dialing (866) 688-0947 (domestic) or (409) 217-8781 (international) and refer to the conference ID 8279646. A telephonic replay will be available beginning approximately four hours after the call through January 2, 2018, and may be accessed by dialing (855) 859-2056 (domestic) or (404) 537-3406 (international). The replay conference ID is 8279646. The webcast replay will be available for two weeks.

About Twist Bioscience Corporation

We are a leading and rapidly growing synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of our platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. We are leveraging our unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. We are also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. We make products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.

Follow us on Twitter | Facebook | LinkedIn

View source version on businesswire.com:https://www.businesswire.com/news/home/20181205005243/en/

CONTACT: Investor Contact:

Argot Partners

Maeve Conneighton

212-600-1902

maeve@argotpartners.comMedia Contact:

Angela Bitting

925- 202-6211

media@twistbioscience.com

KEYWORD: UNITED STATES NORTH AMERICA CALIFORNIA

INDUSTRY KEYWORD: TECHNOLOGY DATA MANAGEMENT HEALTH BIOTECHNOLOGY GENETICS RESEARCH SCIENCE

SOURCE: Twist Bioscience Corporation

Copyright Business Wire 2018.

PUB: 12/05/2018 08:00 AM/DISC: 12/05/2018 08:01 AM

http://www.businesswire.com/news/home/20181205005243/en

AP RADIO
Update hourly